February 7th, 2012
(APDN.OB) Applied DNA Sciences Moves Forward Within Government, Banking, And Insurance Industries
Posted on 16. Mar, 2011 by PublicWire
(PublicWire.com News Release) Applied DNA Sciences, Inc. (OTCQB:APDN), announces new customers and inquiries within the governments and the banking and insurance industries.
Applied DNA provides DNA markers to protect cash and valuables in transit (CViT), to protectbrand owners, and to secure legitimate supply chains against the diversion to gray markets and against the infiltration of counterfeit products. The company’s approach to each vertical market has been to sell its unique, uncopyable DNA tags to suppliers whose components enter at the bottom or through multiple points within a supply chain, and then license the platform to “pain
points” that experience the most liability.
Licensing Model Similar to Software Industry
For example, within the cash transportation industry, APDN sells its DNA markers to the security ink users, ATM cassette manufacturers, and cash box manufacturers, who supply their DNA-enhanced products to security companies and ATM owners. However, the security value in the event of theft can only be realized if the risk-owner has licensed the platform from APDN.
License Unlocks the DNA Sequence Key
“Our model is similar to that employed by the software industry,” said Dr. James Hayward, CEO of APDN. “We ensure widespread deployment of our DNA marks within an industry, in the same manner as software developers distribute software via laptops and device manufacturers. Our licensees can only realize the value of the DNA markers, just as software must be licensed to enjoy its value.” He continued: “Our DNA sequence content is only available to our licensees.
We maintain control of our sequences, and only we can authenticate the cash stolen and provide forensic support in an act perpetrated against a risk-owner, which is initially the cash-intransit transporter, but ultimately includes the financial institution and their insurer.”
APDN now has a proven track record within the CViT industry. With over 22 convictions to its credit, APDN has a 100% conviction record for captured criminals who have stolen cash from its security licensees within the UK. The result, the deterrence provided by APDN, yielded a significant drop in attacks and eliminated cash losses more than one hundred times the cost of annual licensing.
Proven Return on Investment
This proven ROI has brought APDN customers higher up the risk chain. “Banks, insurers and governments are now recognizing the deterrence that can only be provided by DNA markers,” said Dr. Hayward. “We have received initial orders from governments and insurers, and we are fielding inquiries from banks internationally. The increased demand contributed to the closing of the best quarter in our company’s history, announced in SEC filings that describe our first FY11 quarter, ending December 2010.”
About APDN
APDN sells patented DNA security solutions that provide anti-counterfeit protection, as well as protecting brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used for product authentication in a unique manner that essentially cannot be copied. When used in conjunction with other law enforcement technologies, SigNature DNA can provide a forensic chain of evidence that has been used successfully in more than 22 convictions. To learn more, go to www.adnas.com where APDN routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to ur short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.
INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848
MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848
FCMN Contact: info@adnas.com
Web site: http://www.adnas.com
Trading Symbols
Applied DNA Sciences trades Over The Counter As APDN (OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN)
About PublicWire.com
PublicWire.com is a Small Cap Financial Press Release Company that uses a variety of cutting edge methods to syndicate your Small Cap Press Release to various news and information outlets. Our press releases have consitantly placed the Small Cap Companies we work with on the first result page of major search engines such as Google, Bing, and Yahoo. We work exclusively with Pinksheet and Over The Counter (PK and OTCBB) Companies to ensure maximum exposure for their Press Releases.
To maximize your OTCBB / Pinksheet / Small Cap Company Press Release, call us directly at 407-218-7446.
OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN
The symbols “OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN” reflect the variety of methods APDN lists their stock as, and were valid at the time of original publication of this press release.
(PublicWire.com News Release) Applied DNA Sciences, Inc. (OTCQB:APDN), announces new customers and inquiries within the governments and the banking and insurance industries.
Applied DNA provides DNA markers to protect cash and valuables in transit (CViT), to protectbrand owners, and to secure legitimate supply chains against the diversion to gray markets and against the infiltration of counterfeit products. The company’s approach to each vertical market has been to sell its unique, uncopyable DNA tags to suppliers whose components enter at the bottom or through multiple points within a supply chain, and then license the platform to “pain
points” that experience the most liability.
Licensing Model Similar to Software Industry
For example, within the cash transportation industry, APDN sells its DNA markers to the security ink users, ATM cassette manufacturers, and cash box manufacturers, who supply their DNA-enhanced products to security companies and ATM owners. However, the security value in the event of theft can only be realized if the risk-owner has licensed the platform from APDN.
License Unlocks the DNA Sequence Key
“Our model is similar to that employed by the software industry,” said Dr. James Hayward, CEO of APDN. “We ensure widespread deployment of our DNA marks within an industry, in the same manner as software developers distribute software via laptops and device manufacturers. Our licensees can only realize the value of the DNA markers, just as software must be licensed to enjoy its value.” He continued: “Our DNA sequence content is only available to our licensees.
We maintain control of our sequences, and only we can authenticate the cash stolen and provide forensic support in an act perpetrated against a risk-owner, which is initially the cash-intransit transporter, but ultimately includes the financial institution and their insurer.”
APDN now has a proven track record within the CViT industry. With over 22 convictions to its credit, APDN has a 100% conviction record for captured criminals who have stolen cash from its security licensees within the UK. The result, the deterrence provided by APDN, yielded a significant drop in attacks and eliminated cash losses more than one hundred times the cost of annual licensing.
Proven Return on Investment
This proven ROI has brought APDN customers higher up the risk chain. “Banks, insurers and governments are now recognizing the deterrence that can only be provided by DNA markers,” said Dr. Hayward. “We have received initial orders from governments and insurers, and we are fielding inquiries from banks internationally. The increased demand contributed to the closing of the best quarter in our company’s history, announced in SEC filings that describe our first FY11 quarter, ending December 2010.”
About APDN
APDN sells patented DNA security solutions that provide anti-counterfeit protection, as well as protecting brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used for product authentication in a unique manner that essentially cannot be copied. When used in conjunction with other law enforcement technologies, SigNature DNA can provide a forensic chain of evidence that has been used successfully in more than 22 convictions. To learn more, go to www.adnas.com where APDN routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to ur short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
SOURCE Applied DNA Sciences, Inc.
INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848
MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848
FCMN Contact: info@adnas.com
Web site: http://www.adnas.com
Trading Symbols
Applied DNA Sciences trades Over The Counter As APDN (OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN)
About PublicWire.com
PublicWire.com is a Small Cap Financial Press Release Company that uses a variety of cutting edge methods to syndicate your Small Cap Press Release to various news and information outlets. Our press releases have consitantly placed the Small Cap Companies we work with on the first result page of major search engines such as Google, Bing, and Yahoo. We work exclusively with Pinksheet and Over The Counter (PK and OTCBB) Companies to ensure maximum exposure for their Press Releases.
To maximize your OTCBB / Pinksheet / Small Cap Company Press Release, call us directly at 407-218-7446.
OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN
The symbols “OTCBB:APDN, APDN.OB, APDN.OTCBB, APDN” reflect the variety of methods APDN lists their stock as, and were valid at the time of original publication of this press release.
Health Sciences Group Quest to be Listed on the OTCBB
Posted on 20. Nov, 2009 by PublicWire in Medical
20 November 2009 (PublicWire) — Health Sciences Group, Inc. (Pink Sheets:HESG) would like to announce that its lawyer Mr. Robert Young is aggressively seeking realtors in the Los Angeles area to open up Health Sciences offices. The company intends on pursuing with new consultant agreement under Marijuana Inc. a joint venture to market management services. “We are still in negotiations with Marijuana Inc. (MJNA) to complete a joint venture or merger or rolling up into a reporting OTCBB shell. We have all intentions of bringing on the best legal team possible and to make medical marijuana acceptable to the public. I can not say it enough — we are not about legalizing pot for recreational purposes-we are against it! We are here for the millions of ill people that could and will greatly benefit from medical marijuana. I have first hand experience with medical marijuana and it works, it eases pain, anxiety, and increases appetite. I witnessed it first hand with the passing of my own father. This is personal to me,” said Thomas Gaffney, President and CEO of Health Sciences Group, Inc.
Gaffney continues, “As far as the companies are concerned, we are in preliminary talks about moving to the OTCBB to provide transparency to the public. Health Sciences’ chief priority is sustainable economic success — a priority shared by all of our employees and management and by me especially. By providing the best possible transparency into our business by joining forces with Medical Marijuana, Inc. and other medical marijuana based companies, this will give us the growth and strength to increase shareholder value. Health Sciences will continue to operate iGoHealthy.org and our magazine iGoHealthy.”
We would appreciate any shareholders opinion or ideas at info@igohealthy.org
ABOUT HEALTH SCIENCES GROUP, INC.
Health Sciences Group, Inc. is a provider of health and wellness services to consumers, physicians and other healthcare professionals through its website, www.igohealthy.org, and health focused publications. The Health Sciences network consists of its public website, www.igohealthy.org, and iGoHealthy Magazine. The Company operates in three segments: Online Services, Publishing and Other Services. The Company is recently exploring options of corporate growth within the Legal Medical Marijuana Industry.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Health Sciences Group, Inc. to be materially different from the statements made herein.
CONTACT: Health Sciences Group, Inc.
Thomas Gaffney, President and CEO
(321) 604-1451